Latest Updates

News

Press Release

Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions

View Article
Press Release

Diasome Pharmaceuticals announces the addition of globally recognized biopharma thought leader and CEO advisor Peter Tollman, PhD as a new Board Member

View Article
News

Coming Soon: OPTI-2 Trial Results to be Presented at ADA on June 7th at 5pm EST

View Article
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press Release
View All

Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Appoints Peter Tollman, Ph.D., as Chairman of the Board

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Launches Groundbreaking OPTI-2 Phase 2b Trial in Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Announces First Closing of Series C Financing Round

View article
Read more
Download article
Press Release
View All

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View article
Read more
Download article